Recommendations on Informational Monitoring of the Safety and Efficacy of Medicinal Products in the Russian Federation as Part of Pharmacovigilance

Monitoring of information on the safety and efficacy of medicinal products that involves searching for data on benefits and risks of the post-approval use of medicinal products is one of the most important pharmacovigilance processes. The aim of the study was to summarise instruments and recommendations for effective monitoring of information on the safety and efficacy of medicinal products. The article presents the results of the analysis of the regulatory framework and modern tools for scientific literature and Internet information monitoring as part of routine pharmacovigilance. The main resources recommended for information monitoring are open-source scientific and medical bibliographic databases; scientific journals; websites of regulatory authorities and international organisations that monitor the efficacy and safety of medicines; social networks; and online patient communities. Drawing upon current regulatory documents and international good pharmacovigilance practices, the article presents recommendations on the number of resources needed for conducting qualitative monitoring and on the formulation and revision of a search strategy. It describes modern technological solutions in the field of information monitoring, substantiating the suitability of new achievements in such areas as Data Science and natural language processing (NLP) for marketing authorisation holders to collect and analyse data on the safety and efficacy of medicinal products. Regular updates of the search strategy and information channels, the use of software products for the automatic collection and analysis of data from various sources, and the creation of a continuous training system for pharmacovigilance specialists will allow for high-quality monitoring of information on the safety and efficacy of medicines.

1. Goloenko NG, Yagudina RI, Kulikov AYu, Serpik VG, Protsenko MV, Karapetyan DG. Results of a sociological survey on the needs of drug safety monitoring specialists for information on the creation of the pharmacovigilance system master file. Bezopasnost' i risk farmakoterapii = Safety and Risk of Pharmacotherapy. 2020;8(2):84–9 (In Russ.) https://doi.org/10.30895/2312-7821-2020-8-2-84-89

2. Beninger P. Pharmacovigilance: an overview. Clin Ther. 2018;40(12):1991–2004. https://doi.org/10.1016/j.clinthera.2018.07.012

3. 18th ISoP Annual Meeting “Pharmacovigilance without borders”. Geneva, Switzerland, 11–14 November, 2018. Drug Saf. 2018;41(11):1103–273. https://doi.org/10.1007/s40264-018-0719-2

4. Sardella M, Belcher G, Lungu C, Ignoni T, Camisa M, Stenver DI, et al. Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance. Ther Adv Drug Saf. 2021;12:20420986211038436. https://doi.org/10.1177/20420986211038436

5. Khan KS, Kunz R, Kleijnen J, Antes G. Five steps to conducting a systematic review. J R Soc Med. 2003;96(3):118–21. https://doi.org/10.1258/jrsm.96.3.118

6. Agoritsas T, Merglen A, Courvoisier DS, Combescure C, Garin N, Perrier A, Perneger TV. Sensitivity and predictive value of 15 PubMed search strategies to answer clinical questions rated against full systematic reviews. J Med Internet Res. 2012;14(3):e85. https://doi.org/10.2196/jmir.2021

7. Koutsomitropoulos DA, Andriopoulos AD. Automated MeSH indexing of biomedical literature using contextualized word representations. In: Maglogiannis I, Iliadis L, Pimenidis E, eds. AIAI 2020: Artificial Intelligence Applications and Innovations. IFIP Advances in Information and Communication Technology book series; Vol. 583. Springer, Cham. https://doi.org/10.1007/978-3-030-49161-1_29

8. Luo Y, Thompson WK, Herr TM, Zeng Z, Berendsen MA, Jonnalagadda SR, et al. Natural language processing for EHR-based pharmacovigilance: a structured review. Drug Saf. 2017;40(11):1075–89. https://doi.org/10.1007/s40264-017-0558-6

9. Mao Y, Lu Z. MeSH now: automatic MeSH indexing at PubMed scale via learning to rank. J Biomed Semant. 2017;8(15):15. https://doi.org/10.1186/s13326-017-0123-3

10. Jagannatha A, Liu F, Liu W, Yu H. Overview of the first natural language processing challenge for extracting medication, indication, and adverse drug events from Electronic Health Record Notes (MADE 1.0). Drug Saf. 2019;42(1):99–111. https://doi.org/10.1007/s40264-018-0762-z